BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $115 at Jefferies
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $66.97 +3.29%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Jefferies analyst Eun K. Yang lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $115.00 (from $118.00) while maintaining a Buy rating.
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $90; Piper Sandler: 'Remain Buyers'
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- MiniMed Group (MMED) PT Raised to $27 at StoneX on Conservative Revenue Guide
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
